Zacks: Analysts Expect Shotspotter Inc (SSTI) Will Post Earnings of $0.08 Per Share

Share on StockTwits

Wall Street analysts forecast that Shotspotter Inc (NASDAQ:SSTI) will announce earnings per share of $0.08 for the current quarter, according to Zacks. Six analysts have provided estimates for Shotspotter’s earnings. The highest EPS estimate is $0.08 and the lowest is $0.07. Shotspotter posted earnings per share of ($0.26) in the same quarter last year, which would suggest a positive year-over-year growth rate of 130.8%. The firm is expected to announce its next earnings results on Tuesday, February 19th.

On average, analysts expect that Shotspotter will report full-year earnings of ($0.02) per share for the current financial year, with EPS estimates ranging from ($0.04) to $0.01. For the next year, analysts anticipate that the business will report earnings of $0.42 per share, with EPS estimates ranging from $0.36 to $0.48. Zacks’ EPS calculations are a mean average based on a survey of sell-side research firms that follow Shotspotter.

Shotspotter (NASDAQ:SSTI) last issued its quarterly earnings results on Tuesday, November 13th. The company reported ($0.13) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.04) by ($0.09). Shotspotter had a negative return on equity of 37.42% and a negative net margin of 17.52%. The firm had revenue of $9.21 million for the quarter, compared to analysts’ expectations of $8.99 million. During the same quarter in the previous year, the firm posted ($0.12) earnings per share. The firm’s revenue for the quarter was up 34.5% compared to the same quarter last year.

A number of analysts have commented on SSTI shares. William Blair started coverage on shares of Shotspotter in a report on Wednesday, September 26th. They set an “outperform” rating for the company. BidaskClub cut shares of Shotspotter from a “buy” rating to a “hold” rating in a research report on Wednesday, October 3rd. Roth Capital boosted their price objective on shares of Shotspotter from $60.00 to $64.00 and gave the company a “buy” rating in a research report on Friday, October 5th. JMP Securities boosted their price objective on shares of Shotspotter from $50.00 to $62.00 and gave the company a “buy” rating in a research report on Monday, October 8th. Finally, National Securities assumed coverage on shares of Shotspotter in a research report on Monday, December 3rd. They issued a “buy” rating and a $38.09 price objective on the stock. Twelve investment analysts have rated the stock with a buy rating, The company currently has an average rating of “Buy” and a consensus target price of $45.71.

Shares of NASDAQ SSTI traded up $1.29 during mid-day trading on Friday, reaching $42.26. The company had a trading volume of 96,507 shares, compared to its average volume of 117,188. Shotspotter has a twelve month low of $15.74 and a twelve month high of $66.14. The company has a market capitalization of $457.34 million, a PE ratio of -74.14, a price-to-earnings-growth ratio of 10.98 and a beta of 2.29.

In other news, VP Joseph O. Hawkins sold 1,911 shares of the company’s stock in a transaction that occurred on Friday, November 16th. The shares were sold at an average price of $29.31, for a total transaction of $56,011.41. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Thomas T. Groos sold 112,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 20th. The stock was sold at an average price of $32.41, for a total transaction of $3,629,920.00. The disclosure for this sale can be found here. Corporate insiders own 36.10% of the company’s stock.

Large investors have recently modified their holdings of the stock. MetLife Investment Advisors LLC bought a new position in Shotspotter in the 2nd quarter valued at approximately $137,000. Reynders McVeigh Capital Management LLC bought a new position in Shotspotter in the 3rd quarter valued at approximately $213,000. State Board of Administration of Florida Retirement System bought a new position in Shotspotter in the 3rd quarter valued at approximately $215,000. LPL Financial LLC bought a new position in Shotspotter in the 3rd quarter valued at approximately $219,000. Finally, Rhumbline Advisers bought a new position in Shotspotter in the 2nd quarter valued at approximately $237,000. 55.34% of the stock is owned by institutional investors and hedge funds.

About Shotspotter

ShotSpotter, Inc provides software-as-a-service based gunshot detection solutions for law enforcement officials and security personnel in the United States, South Africa, and internationally. The company's solutions include ShotSpotter Flex, an outdoor public safety solution for cities and municipalities to identify, locate, and deter gun violence by incorporating a real-time gunshot detection system into their policing systems; and SST SecureCampus that helps the law enforcement and security personnel serving universities, colleges, and other educational institutions to mitigate risk and enhance security by notifying authorities and first responders of an active-shooter.

See Also: What is the Current Ratio?

Get a free copy of the Zacks research report on Shotspotter (SSTI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Shotspotter Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shotspotter and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Jonathan Corr Sells 12,515 Shares of Ellie Mae Inc  Stock
Jonathan Corr Sells 12,515 Shares of Ellie Mae Inc Stock
T-Mobile Us Inc  Insider Thomas Christopher Keys Sells 43,000 Shares
T-Mobile Us Inc Insider Thomas Christopher Keys Sells 43,000 Shares
Astrotech  Shares Up 6.5%
Astrotech Shares Up 6.5%
Teekay Offshore Partners  Trading 5.2% Higher
Teekay Offshore Partners Trading 5.2% Higher
Workiva  Issues Q1 2019 Earnings Guidance
Workiva Issues Q1 2019 Earnings Guidance
Autolus Therapeutics Ltd –  Receives $44.00 Consensus PT from Analysts
Autolus Therapeutics Ltd – Receives $44.00 Consensus PT from Analysts


© 2006-2019 Ticker Report